The Effect of Bevacizumab-Related Hypertension on the Prognosis of Patients with Colorectal Cancer and Non-Small Cell Lung Cancer

被引：0
|
作者：
Pan, Juhua [1 ]
Zheng, Liangda [2 ]
Liu, Binghui [1 ]
You, Shuqing [1 ]
Zheng, Weizhi [1 ]
机构：
[1] Taizhou First Peoples Hosp, Dept Pathol, Taizhou 318020, Zhejiang, Peoples R China
[2] Taizhou First Peoples Hosp, Dept Hematol, Taizhou 318020, Zhejiang, Peoples R China
来源：
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2022年 / 84卷
关键词：
Bevacizumab; hypertension; colorectal cancer; non-small cell lung cancer; prognosis;
D O I：
10.36468/pharmaceutical-sciences.spl.448
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
To study and analyze the effect of bevacizumab-related hypertension on the prognosis of patients with colorectal cancer and non-small cell lung cancer. The study randomly selected 100 colorectal cancer patients and 100 non-small cell lung cancer patients who received therapy in our hospital from October 2019 to October 2021. Among them, adopted intervention for 100 colorectal cancer patients with bevacizumab combined with cytotoxic drug chemotherapy and adopted intervention for 100 non-small cell lung cancer patients with bevacizumab combined with standard chemotherapy. Bevacizumab treatment has better therapeutic effect of hypertension on colorectal cancer patients than non-small cell lung cancer patients. Compared with colorectal cancer patients who received bevacizumab treatment, non-small cell lung cancer patients under bevacizumab treatment caused more adverse reactions. Among 100 colorectal cancer patients, the number of patients with bevacizumab-related hypertension in grade 1, grade 2 and grade 3 were 45, 12 and 23 respectively. Among 100 non-small cell lung cancer patients, the number of patients with bevacizumab-related hypertension in grade 1, grade 2 and grade 3 were 44, 25 and 20 respectively. Bevacizumab-related hypertension can improve the prognosis and efficacy of colorectal cancer and non-small cell lung cancer patients.
引用
收藏
页码：21 / 24
页数：4
相关论文
共 50 条
  • [1] Bronchoscopic findings for bevacizumab-related pulmonary hemorrhage in advanced non-small cell lung cancer
    Okamoto, Kunio
    Okamoto, Isamu
    Miyazaki, Masaki
    Tanaka, Kaoru
    Kaneda, Hiroyasu
    Nakagawa, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (05) : 1364 - 1366
  • [2] Clinical risk factors of bevacizumab-related hypertension in patients with metastatic colorectal cancer: a retrospective study
    Zheng, Zhuoling
    Zhao, Yihong
    Xie, Jingwen
    Gao, Min
    Wang, Yiting
    Li, Xiaoyan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [3] Association of hypertension and treatment outcomes in advanced stage non-small cell lung cancer patients treated with bevacizumab or non-bevacizumab containing regimens
    Yan, Lily Z.
    Dressler, Emily V.
    Adams, Val R.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (03) : 209 - 217
  • [4] Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients
    Alfonso De Stefano
    Chiara Carlomagno
    Stefano Pepe
    Roberto Bianco
    Sabino De Placido
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 1207 - 1213
  • [5] Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients
    De Stefano, Alfonso
    Carlomagno, Chiara
    Pepe, Stefano
    Bianco, Roberto
    De Placido, Sabino
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (05) : 1207 - 1213
  • [6] Bevacizumab in Non-Small Cell Lung Cancer
    Francesco Di Costanzo
    Francesca Mazzoni
    Marinella Micol Mela
    Lorenzo Antonuzzo
    Daniele Checcacci
    Matilde Saggese
    Federica Di Costanzo
    Drugs, 2008, 68 : 737 - 746
  • [7] Spotlight on Bevacizumab in Advanced Colorectal Cancer, Breast Cancer, and Non-Small Cell Lung Cancer
    Katherine A. Lyseng-Williamson
    Dean M. Robinson
    BioDrugs, 2006, 20 : 193 - 195
  • [8] Incidence and management of bevacizumab-related toxicities in colorectal cancer
    Saif, M. Wasif
    Mehra, Ranee
    EXPERT OPINION ON DRUG SAFETY, 2006, 5 (04) : 553 - 566
  • [9] Bronchoscopic findings for bevacizumab-related pulmonary hemorrhage in advanced non–small cell lung cancer
    Kunio Okamoto
    Isamu Okamoto
    Masaki Miyazaki
    Kaoru Tanaka
    Hiroyasu Kaneda
    Kazuhiko Nakagawa
    Investigational New Drugs, 2013, 31 : 1364 - 1366
  • [10] Prognosis in Patients with Non-Small Cell Lung Cancer and Satellite Tumors
    Kocaturk, C. I.
    Gunluoglu, M. Z.
    Cansever, L.
    Dincer, I. S.
    Bedirhan, M. A.
    THORACIC AND CARDIOVASCULAR SURGEON, 2011, 59 (06) : 360 - 363
12345